June 1, 2022 | Portfolio News

Moxe Health Raises $30M Series B to Further Advance Interoperability

20

Novel FDA PMA & de novo 510k approvals

55

U.S. Commercial Product Launches

39

Level I Clinical Trials

29

Strategic Financings

30

Exits by IPO or M&A